Table 2.
Pathological characteristics at biopsy | Propensity matched cohort | ||
---|---|---|---|
Nonproteinurics (n = 82) | Proteinurics (n = 164) | p value | |
Fioretto classification (%) | < 0.001 | ||
CI | 62 | 17 | |
CII | 20 | 66 | |
CIII | 18 | 17 | |
Tervaert (RPS) classification (%) | < 0.001 | ||
I | 31 | 4 | |
IIa | 22 | 14 | |
IIb | 10 | 20 | |
III | 25 | 52 | |
IV | 2 | 10 | |
Japanese classification | |||
Glomerular lesions | |||
GS (%) | 16 (6, 37) | 33 (17, 44) | < 0.001 |
Diffuse lesion (%) | < 0.001 | ||
0 | 16 | 1 | |
1 | 43 | 17 | |
2 | 17 | 29 | |
3 | 24 | 53 | |
GBM doubling (%) | 0.001 | ||
0 | 66 | 23 | |
1 | 17 | 41 | |
2 | 8 | 23 | |
3 | 9 | 13 | |
Exudative lesion (%) | 24 | 61 | < 0.001 |
Nodular lesion (%) | 22 | 54 | < 0.001 |
Mesangiolysis (%) | 19 | 49 | < 0.001 |
Polar vasculosis (%) | 54 | 73 | 0.014 |
Glomerulomegaly (%) | 26 | 37 | 0.13 |
Interstitial lesions | |||
IFTA (%) | < 0.001 | ||
0 | 11 | 2 | |
1 | 53 | 24 | |
2 | 23 | 37 | |
3 | 13 | 37 | |
Inflammation (%) | 0.021 | ||
0 | 15 | 4 | |
1 | 62 | 64 | |
2 | 18 | 22 | |
3 | 5 | 10 | |
Vascular lesions | |||
Arteriolar hyalinosis (%) | 0.002 | ||
0 | 15 | 4 | |
1 | 23 | 16 | |
2 | 29 | 48 | |
3 | 33 | 32 | |
Arteriosclerosis (%) | 0.002 | ||
0 | 16 | 5 | |
1 | 35 | 51 | |
2 | 47 | 44 | |
3 | 2 | 0 |
Adapted from Yamanouchi et al. [24]. Copyright 2019 by the American Diabetes Association
Data are expressed as the mean (standard deviation), median (25th, 75th percentiles), or percentage
Fioretto Classification; CI, normal or near normal renal structure; CII, typical diabetic kidney disease; CIII, A typical patterns of renal injury; Tervaert (RPS) classification, Renal Pathology Society diabetic kidney disease classification; I; Mild or nonspecific light microscopy changes and electron microscopy-proven glomerular membrane thickening; IIa; Mild mesangial expansion; IIb, Severe mesangial expansion; III; Nodular sclerosis (Kimmelstiel-Wilson lesion); IV, Advanced diabetic glomerulosclerosis; GS, percentage of glomerulosclerosis defined as the number of global or segmental sclerosis glomeruli per total glomeruli; GBM, glomerular basement membrane; IFTA, interstitial fibrosis and tubular atrophy